A Tampa veteran living with a rare muscle disease has had a key benefits denial reversed after local investigative journalists put a spotlight on his case. The Department of Veterans Affairs announced the changes yesterday, following 10Tampa Bay’s "Diagnosis Denied" documentary, which highlighted veterans who say the agency has repeatedly turned down claims for inclusion body myositis. The reversal restores the benefits and support the veteran had been seeking.
VA Reopens Case After TV Investigation Turns Up Heat
According to 10Tampa Bay, VA officials took a second look at the veteran’s file after the station’s reporting and on May 18 reversed the earlier denial. The station reported that until the agency backed off its first decision, the veteran had been left without disability compensation or caregiver supports tied to the claim. WTSP also noted that VA officials did not immediately release the veteran’s name or full medical records.
What Is Inclusion Body Myositis?
Inclusion body myositis, or IBM, is a progressive muscle disease that usually appears in people over 50 and leads to muscle weakness, frequent falls, and difficulty swallowing, according to NINDS. Diagnosis can take years, in part because symptoms creep in slowly and can be mistaken for other conditions. Those delays can make VA claims harder to win, since veterans must show evidence that links a confirmed diagnosis to their military service under the agency’s decision review rules.
Research Points to Molecular Overlaps
Researchers have identified molecular overlaps between IBM and neurodegenerative diseases such as ALS, including accumulations of the TDP-43 protein in affected tissue. A peer-reviewed analysis found TDP-43 pathology in many IBM muscle biopsies and helped steer more research attention toward shared disease mechanisms, as reported in Scientific Reports. Clinicians focused on neuromuscular disease, including Thomas Lloyd, are working to turn that molecular insight into clearer diagnostic criteria and future treatment trials.
Advocates Press for Policy Change as Reviews Continue
Advocacy groups say this reversal fits into a broader push to have IBM treated as a presumptive condition for veterans, so they are not forced into drawn-out, one-off appeals. The Myositis Association reports that the National Academies is reviewing IBM as part of a larger study on military exposures, with a final report expected in July 2027. Veterans and advocates hope those findings will spur VA rulemaking. Hoodline has previously covered one of the veterans at the center of this fight in an April feature about a Portland man who spent years trying to secure benefits.
How Veterans Can Follow Up
Veterans who suspect they have IBM and need help with appeals can review the VA’s decision review options and appeal pathways online and work with accredited veterans service officers, according to VA Decision Reviews. The nationwide "Diagnosis Denied" project is streaming on a TEGNA platform and has inspired local reporting that advocates and attorneys say is helping the agency spot cases that warrant another look. The Myositis Association also maintains educational materials and sample letters that can help veterans navigate IBM-related claims and appeals.
